The invention discloses a novel
camptothecin compound or a stereoisomer or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the
camptothecin compound or the stereoisomer or the pharmaceutically acceptable salt, and application of the
camptothecin compound or the stereoisomer or the pharmaceutically acceptable salt as an antitumor
drug. According to the structure, R1, R2 and R3 are independently selected from
hydrogen,
deuterium,
halogen, hydroxyl, cyano, sulfydryl,
sulfuryl,
sulfoxide, nitro, substituted or unsubstituted amido, carboxyl, acylamino, deuterated
alkyl, C1-6
alkyl, C1-6 alkoxy, C1-6 halogenated
alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, C3-6 heterocyclic radical,
aryl or heteroaryl; or R1 and R2 as well as R2 and R3 are respectively connected with adjacent carbon atoms to form 5-7-membered cycloalkyl or heterocycloalkyl; the 5-to 7-membered cycloalkyl or heterocyclic cycloalkyl is optionally substituted by one or more halogens or
deuterium atoms, alkyl and alkoxy. The compound has a good anti-tumor effect.